Redefining Clostridioides difficile infection antibiotic response and clinical outcomes-Reference-Cited by-同舟云学术

Redefining Clostridioides difficile infection antibiotic response and clinical outcomes

Published:2023-07 Issue:7 Volume:23 Page:e259-e265
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Gonzales-Luna Anne J,Skinner Andrew M,Alonso Carolyn D,Bouza Emilio,Cornely Oliver A,de Meij Tim G J,Drew Richard J,Garey Kevin W,Gerding Dale N,Johnson Stuart,Kahn Stacy A,Kato Haru,Kelly Ciaran P,Kelly Colleen R,Kociolek Larry K,Kuijper Ed J,Louie Thomas,Riley Thomas V,Sandora Thomas J,Vehreschild Maria J G T,Wilcox Mark H,Dubberke Erik R

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference38 articles.

1. Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis;Teasley;Lancet,1983

2. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity;Zar;Clin Infect Dis,2007

3. Fidaxomicin versus vancomycin for Clostridium difficile infection;Louie;N Engl J Med,2011

4. Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial;Cornely;Lancet Infect Dis,2012

5. Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials;Johnson;Clin Infect Dis,2014

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibiotic resistance of Escherichia coli isolated from food and clinical environment in China from 2001 to 2020;Science of The Total Environment;2024-08

2. Alcohol in Baijiu Contributes to the Increased Probability of Host Infection by Clostridioides difficile Spores;Foodborne Pathogens and Disease;2024-07-25

3. A retrospective budget impact analysis of fidaxomicin treatment for Clostridioides difficile infections (CDI) in Germany;Expert Review of Pharmacoeconomics & Outcomes Research;2024-05-09

4. Which trial do we need? A sequential multiple assignment randomized trial to determine the optimal Clostridioides difficile treatment sequence;Clinical Microbiology and Infection;2024-02

5. The effect of antibiotic therapy for Clostridioides difficile infection on mortality and other patient-relevant outcomes: a systematic review and meta-analysis;Clinical Microbiology and Infection;2024-01